Related references
Note: Only part of the references are listed.MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
Nikhil Wagle et al.
CANCER DISCOVERY (2014)
Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
Jean-Francois Emile et al.
BMC CANCER (2013)
Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations
L. Heinzerling et al.
BRITISH JOURNAL OF CANCER (2013)
Multiple primary melanomas: do they look the same?
E. Moscarella et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance
Antonia L. Pritchard et al.
CLINICAL CANCER RESEARCH (2013)
Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma
Wesley O. Greaves et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Future perspectives in melanoma research. Meeting report from the Melanoma Bridge. Napoli, December 2nd-4th 2012
Paolo A. Ascierto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
Maria Colombino et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma
Matteo S. Carlino et al.
MOLECULAR CANCER THERAPEUTICS (2013)
MAP kinase signaling and inhibition in melanoma
R. J. Sullivan et al.
ONCOGENE (2013)
Clinicopathologic Features of Incident and Subsequent Tumors in Patients with Multiple Primary Cutaneous Melanomas
Rajmohan Murali et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
Maria Colombino et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy
M. Colombino et al.
CELL DEATH & DISEASE (2012)
Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression
J. Lin et al.
BRITISH JOURNAL OF CANCER (2011)
Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis
J. -H. Lee et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma
Yan Kong et al.
CLINICAL CANCER RESEARCH (2011)
The role of mitogen- and stress-activated protein kinase pathways in melanoma
Pablo Lopez-Bergami
PIGMENT CELL & MELANOMA RESEARCH (2011)
Multiple primary melanoma: the impact of atypical naevi and follow up
V. de Giorgi et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Somatic Alterations in the Melanoma Genome: A High-Resolution Array-Based Comparative Genomic Hybridization Study
Andreas Gast et al.
GENES CHROMOSOMES & CANCER (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Main roads to melanoma
Giuseppe Palmieri et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma
Viktoria Lazar et al.
MODERN PATHOLOGY (2009)
Cutaneous melanoma in the era of molecular profiling
John F. Thompson et al.
LANCET (2009)
KIT Gene Mutations and Copy Number in Melanoma Subtypes
Carol Beadling et al.
CLINICAL CANCER RESEARCH (2008)
The MAPK pathway in melanoma
Leslie A. Fecher et al.
CURRENT OPINION IN ONCOLOGY (2008)
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas
Keiran S. M. Smalley et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization
Katharina Glatz-Krieger et al.
VIRCHOWS ARCHIV (2006)
Mechanisms of disease - Melanoma
Arlo J. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Anatomic site, sun exposure, and risk of cutaneous melanoma
David C. Whiteman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinicopathological features of and risk factors for multiple primary melanomas
CR Ferrone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors
S Gandini et al.
EUROPEAN JOURNAL OF CANCER (2005)
Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families
V Chaudru et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
The INK4a/ARF locus and melanoma
NE Sharpless et al.
ONCOGENE (2003)
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
A Tannapfel et al.
GUT (2003)
Multiple synchronous cutaneous melanomas: implications for prevention
P Carli et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Share Paper
